Diabetes Newsletter – Treat-to-target and noninferiority design in insulin studies – Issue 6 – Mainpro+
CAN-eng
$0
gratuit
Mainpro+
Diabète
0.25 Credits
Description du cours
Détails du cours
Date d'expiration : 2014-07-18
Métiers: Médecin
Faculté
Accréditation
Objectif(s) d'apprentissage
- Understand the clinical and pharmacoeconomic utility of noninferiority studies
- Understand the rationale for treat-to-target trials and approaches in type 2 diabetes.
[rxbc_in_template_course_button enrol_button_text = 'Start Course' access_button_text ='Resume Course']